Upcoming Conference Presentations by Carisma Therapeutics
Carisma Therapeutics Inc. (Nasdaq: CARM), a clinical-stage biopharmaceutical company at the forefront of innovative immunotherapies, has announced its participation in several key conferences in the coming weeks. Led by Steven Kelly, the President and CEO, these presentations will highlight Carisma's pioneering research and advancements in the field of immunotherapy.
Conference Highlights
Baird 2024 Global Healthcare Conference
This conference is set for Tuesday, September 10, at 12:50 PM ET in New York. It offers an excellent opportunity for Carisma to engage with stakeholders and present its latest advancements.
H.C. Wainwright 26th Annual Global Investment Conference
On Wednesday, September 11, Carisma will present at 1:30 PM ET in New York, sharing insights into its ongoing projects and future strategic direction.
Chardan's 8th Annual Genetic Medicines Conference
Scheduled for Monday, September 30, Carisma's presentation will take place at 4:00 PM ET in New York, focusing on the company’s innovative strategies in genetic medicine and immunotherapy.
The Cell & Gene Meeting on the Mesa
This important meeting is happening on Monday, October 7, at 9:30 AM MST in Phoenix, Arizona. It will provide Carisma with a valuable platform to connect with industry leaders and discuss its unique therapeutic approaches.
Webcast Access for Conference Presentations
If you can't attend the conferences in person, live webcasts of the presentations will be available on Carisma's Investor Events page. Additionally, recordings of the webcasts will be accessible for a limited time after each event, allowing interested individuals to catch up on the discussions at their convenience.
About Carisma Therapeutics
Carisma Therapeutics Inc. was founded with the mission to revolutionize cancer treatment through a proprietary cell engineering platform that develops advanced immunotherapies. The company leverages engineered macrophages and monocytes to enhance immune responses against serious diseases, offering innovative therapeutic solutions. For more information about Carisma and its mission, please visit www.carismatx.com.
Contact Information
For Investors
Shveta Dighe
Head of Investor Relations
[email protected]
For Media Inquiries
Julia Stern
(763) 350-5223
[email protected]
Frequently Asked Questions
What is the focus of Carisma Therapeutics?
Carisma Therapeutics is committed to developing innovative immunotherapies aimed at treating cancer and other serious diseases through its proprietary cell therapy platform.
Who will represent Carisma at the upcoming conferences?
Steven Kelly, the President and CEO of Carisma Therapeutics, will be the representative for the company at these conferences.
When is the Baird 2024 Global Healthcare Conference scheduled?
The Baird 2024 Global Healthcare Conference is set for September 10, 2024, at 12:50 PM ET in New York.
How can I access the webcasts for the conferences?
The webcasts will be available on Carisma's Investor Events webpage during the events and will be archived for a limited time afterward.
Where can I find more information about Carisma Therapeutics?
For further information, you can visit Carisma Therapeutics' official website at www.carismatx.com.